GUADALUPE CHAVEZ: Open Payments
NPI 1114569241 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 11 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $33 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $128 |
| Immunocore Limited | 2 | $81 |
| Dexcom, Inc. | 1 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Organon LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: REPATHA, KIMMTRAK, Dexcom G6 Transmitter, JARDIANCE, NEXPLANON, GARDASIL 9, OTEZLA, WAINUA.
Industry payments across CA — which companies pay providers there.
